Great Point Partners LLC cut its stake in shares of UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) by 93.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 39,222 shares of the company’s stock after selling 520,778 shares during the period. Great […]
UroGen Pharma Ltd. (NASDAQ:URGN – Get Free Report) General Counsel Jason Drew Smith sold 3,800 shares of UroGen Pharma stock in a transaction on Thursday, August 31st. The shares were sold at an average price of $18.01, for a total transaction of $68,438.00. Following the completion of the transaction, the general counsel now directly owns […]
UroGen Pharma (NASDAQ:URGN) Earns Buy Rating from HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
UroGen Pharma Ltd. (NASDAQ:URGN – Get Free Report) was the target of a significant increase in short interest in July. As of July 31st, there was short interest totalling 1,570,000 shares, an increase of 55.4% from the July 15th total of 1,010,000 shares. Based on an average trading volume of 553,600 shares, the short-interest ratio […]
UroGen Pharma (NASDAQ:URGN – Get Free Report) is scheduled to be announcing its earnings results before the market opens on Thursday, August 10th. Analysts expect the company to announce earnings of ($1.13) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link. UroGen […]